» Articles » PMID: 37605057

Glutarate Regulates T Cell Metabolism and Anti-tumour Immunity

Abstract

T cell function and fate can be influenced by several metabolites: in some cases, acting through enzymatic inhibition of α-ketoglutarate-dependent dioxygenases, in others, through post-translational modification of lysines in important targets. We show here that glutarate, a product of amino acid catabolism, has the capacity to do both, and has potent effects on T cell function and differentiation. We found that glutarate exerts those effects both through α-ketoglutarate-dependent dioxygenase inhibition, and through direct regulation of T cell metabolism via glutarylation of the pyruvate dehydrogenase E2 subunit. Administration of diethyl glutarate, a cell-permeable form of glutarate, alters CD8 T cell differentiation and increases cytotoxicity against target cells. In vivo administration of the compound is correlated with increased levels of both peripheral and intratumoural cytotoxic CD8 T cells. These results demonstrate that glutarate is an important regulator of T cell metabolism and differentiation with a potential role in the improvement of T cell immunotherapy.

Citing Articles

Eight weeks of aerobic exercise, but not four, improves insulin sensitivity and cardiovascular performance in young women.

Sellami M, Almuraikhy S, Naja K, Anwardeen N, Al-Amri H, Prince M Sci Rep. 2025; 15(1):1991.

PMID: 39815028 PMC: 11735795. DOI: 10.1038/s41598-025-86306-2.


Mechanisms of metabolism-coupled protein modifications.

Zhang B, Schroeder F Nat Chem Biol. 2025; .

PMID: 39775169 DOI: 10.1038/s41589-024-01805-z.


Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer.

Viel S, Vivier E, Walzer T, Marcais A Nat Rev Drug Discov. 2024; 24(3):190-208.

PMID: 39668206 DOI: 10.1038/s41573-024-01098-w.


Research Hotspots and Trends in Global Cancer immunometabolism:A Bibliometric Analysis from 2000 to 2023.

Chen S, Liu J, He G, Tang N, Zeng Y J Multidiscip Healthc. 2024; 17:5117-5137.

PMID: 39553266 PMC: 11568773. DOI: 10.2147/JMDH.S495330.


Optimizing CD8 T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators.

Zhou Z, Zheng J, Lu Y, Mai Z, Lin Y, Lin P Exp Hematol Oncol. 2024; 13(1):103.

PMID: 39438986 PMC: 11495118. DOI: 10.1186/s40164-024-00575-7.


References
1.
Kaech S, Cui W . Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol. 2012; 12(11):749-61. PMC: 4137483. DOI: 10.1038/nri3307. View

2.
Sallusto F, Lanzavecchia A, Araki K, Ahmed R . From vaccines to memory and back. Immunity. 2010; 33(4):451-63. PMC: 3760154. DOI: 10.1016/j.immuni.2010.10.008. View

3.
Crompton J, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W . Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol. 2015; 13(4):502-13. PMC: 4947817. DOI: 10.1038/cmi.2015.32. View

4.
Harland K, Day E, Apte S, Russ B, Doherty P, Turner S . Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming. Nat Commun. 2014; 5:3547. PMC: 3974221. DOI: 10.1038/ncomms4547. View

5.
Russ B, Olshanksy M, Smallwood H, Li J, Denton A, Prier J . Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. Immunity. 2014; 41(5):853-65. PMC: 4479393. DOI: 10.1016/j.immuni.2014.11.001. View